Angiotensin II activates nuclear transcription factor κB through AT1 and AT2 in vascular smooth muscle cells molecular mechanisms

Circulation Research

Volumn 86, Issue 12, 2000, Pages 1266-1272

  Ruiz Ortega, Marta ^a   Lorenzo, Oscar ^b   Rupérez, Mónica ^b   König, Sven ^b   Wittig, Burghardt ^b   Egido, Jesús ^b  

^a Renal Research Laboratory   (Spain)

^b NONE

Author keywords

Angiotensin II; Nuclear factor B; Receptors; Vascular smooth muscle cell

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA BINDING; GENETIC TRANSCRIPTION; HORMONE RECEPTOR INTERACTION; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

EID: 0034705372     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.86.12.1266     Document Type: Article

References (37)

1. Baker KM, Booz GW, Dostal DE. Cardiac actions of angiotensin II: role of an intracardiac renin-angiotensin system. Annu Rev Physiol. 1992;54: 227-241.
2. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RW, Saye JAM, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonist. Pharmacol Rev. 1993; 45:205-251.
3. Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res. 1998;83:1182-1191.
4. Griedling KK, Ushio-Fukai M, Lassègue B, Alexander RW. Angiotensin II signaling in vascular smooth muscle cells. Hypertension. 1997;29: 366-373.
5. Wolf G, Ziyadeh FN, Thaiss F, Tomaszewiski J, Caron RJ, Wenzel U, Zahner G, Helmchen U, Stahl RAK. Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells: role of the angiotensin type 2 receptor. J Clin Invest. 1997;100:1047-1058.
6. Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, Delafontaine P, Bernstein KE. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature. 1995;375:247-250.
7. Takeuchi K, Nakemura N, Cook NS, Pratt RE, Dzau VJ. Angiotensin II can regulate gene expression by the AP-1 binding sequence via a protein kinase C-dependent pathway. Biochem Biophys Res Commun. 1990;172: 1189-1194.
8. Hernández-Presa M, Bustos C, Ortego M, Tuñón J, Ruiz-Ortega M, Egido J. Angiotensin converting enzyme inhibition prevents arterial NF-κB activation, MCP-1 expression and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation. 1997;95: 1532-1541.
9. Ruiz-Ortega M, Bustos C, Hernández-Presa MA, Lorenzo O, Plaza JJ, Egido J. Angiotensin II participates in mononuclear cell recruitment in the kidney through nuclear factor-κB activation and monocyte chemoattractant protein-1 gene expression. J Immunol. 1998;161:430-439.
10. Barnes PJ, Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997;336:1066-1071.
11. Brasier AR, Li J. Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension. 1996;27:465-475.
12. Linder V, Collins T. Expression of NF-κB and IκB by aortic endothelium in an arterial injury model. Am J Pathol. 1996;148:427-438.
13. Kalkbrenner F, Dippel E, Schroff M, Wittig B, Schultz G. Nuclear application of antisense oligonucleotides by microinjection and ballistomagnetic transfer to identify G protein heterotrimers activating phospholipase C. Methods Mol Biol. 1997;83:203-216.
14. Kambayashi H, Bardham S, Inagami T. Peptide growth factors markedly decrease the ligand binding of angiotensin type-2 receptor in rat cultured vascular smooth muscle cells. Biochem Biophys Res Commun. 1993;194: 478-482.
15. Speth RC, Kim KH. Discrimination of two angiotensin II receptor subtypes with a selective agonist analogue of angiotensin II, p-aminophenylalanine6-angiotensin II. Biochem Biophys Res Commun. 1990;169:997-1006.
16. Sen CK, Packer L. Antioxidants and redox regulation of gene transcription. FASEB J. 1996;10:709-720.
17. Schutze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Kronke M. TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell. 1992;71:765-776.
18. Han Y, Runge MS, Brasier AR. Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-κB transcription factors. Circ Res. 1999;84: 695-703.
19. Crawford DC, Chobanian AV, Brecher P. Angiotensin II induces fibronectin expression associated to cardiac fibrosis in the rat. Circ Res. 1994;74:727-739.
20. Sadoshima J, Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts: critical role of the AT1 receptor subtype. Circ Res. 1993;73: 413-423.
21. Seyedi N, Xu X, Nasjletti A, Hintze TH. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension. 1995;26:164-170.
22. Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol. 1994;26:809-820.
23. Yang CH, Shyr MH, Tan PP, Chan SH. Participation of AT1 and AT2 receptors in the differential interaction between angiotensin II or III and α-2 adrenoceptors in the nucleus reticularis gigantocellularis in cardiovascular regulation and antinociception in rats. J Pharmacol Exp Ther. 1996;279:795-802.
24. Martin T, Cardarelli PM, Parry GC, Felts KA, Cobb RR. Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-κB and AP-1. Eur J Immunol. 1997;27:1091-1097.
25. Capers Q 4th, Alexander RW, Lou P, De Leon H, Wilcox JN, Ishizaka N, Howard AB, Taylor WR Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats. Hypertension. 1997;30:1397-1402.
26. Tummala PE, Chen XL, Sundell CL, Laursen JB, Hammes CP, Alexander RW, Harrison DG, Medford RM. Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: a potential link between the renin-angiotensin system and atherosclerosis. Circulation. 1999;100:1223-1229.
27. Clozel M, Kuhn H, Hefti F, Baumgartner HR. Endothelial dysfunction and subendothelial monocyte macrophages in hypertension: effect of angiotensin converting enzyme inhibition. Hypertension. 1991;18: 132-141.
28. Blanco-Colio LM, Hernandez-Presa MA, Ortego M, Martin-Ventura JL, Tunon J, Egido J. Potential role of apoptosis in atherosclerosis. Cardiovasc Risk Factors. 1999;9:169-174. Available at http://www.crf. medynet.com.
29. Barinaga M. Life-death balance within the cell. Science. 1996;274:724.
30. Diep QN, Li JS, Schiffrin EL. In vivo study of AT(1) and AT(2) angiotensin receptors in apoptosis in rat blood vessels. Hypertension. 1999;34: 617-624.
31. Lehtonen JYA, Horiuchi M, Daviet L, Akishita M, Dzau VJ. Activation of the de novo biosynthesis of sphingolipids mediates angiotensin II type 2 receptor-induced apoptosis. J Biol Chem. 1999;274:16901-16906.
32. Chaturvedi MM, Kumar A, Darnay BG, Chainy GBN, Agarwal S, Agarwal BB. Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-κB activation, I-κBα phosphorylation and degradation. J Biol Chem. 1997;272:30129-30134.
33. Meichle A, Schutze S, Hensel G, Brunsing D, Kronke M. Protein kinase C-independent activation of nuclear factor-κB by tumor necrosis factor. J Biol Chem. 1990;265:8339-8343.
34. Barchowsky A, Munro SR, Morana SJ, Vincenti MP, Treadwell M. Oxidant-sensitive and phosphorylation-dependent activation of NF-κB and AP-1 in endothelial cells. Am J Physiol. 1995;269:L829-L836.
35. Garcia J, Lemercier B, Roman-Roman S, Rawadi G. A Mycoplasma fermentans-derived synthetic lipopeptide induces AP-1, and NF-κB activity, and cytokine secretion in macrophages via the activation of mitogen-activated protein kinase pathways. J Biol Chem. 1998;273: 34391-34398.
36. Bergmann M, Hart L, Lindsay M, Barnes PJ, Newton R. IκBα degradation and nuclear factor-κB DNA binding are insufficient for interleukin-1β and tumor necrosis factor-α-induced κB-dependent transcription: requirement for an additional activation pathway. J Biol Chem. 1998;273:6607-6610.
37. Chen XL, Tummala PE, Olbrych MT, Alexander RW, Medford RM. Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res. 1998;83: 952-959.